Display options
Share it on

Oncotarget. 2017 Jun 16;8(45):79507-79516. doi: 10.18632/oncotarget.18525. eCollection 2017 Oct 03.

Surgical management for follicular variant of papillary thyroid carcinoma.

Oncotarget

Jianing Tang, Deguang Kong, Lupin Bu, Gaosong Wu

Affiliations

  1. Department of Breast and Thyroid Surgery, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, P.R. China.
  2. Department of General Surgery, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, P.R. China.

PMID: 29108330 PMCID: PMC5668063 DOI: 10.18632/oncotarget.18525

Abstract

BACKGROUND AND AIMS: For most patients with follicular variant of papillary thyroid carcinoma (FVPTC), surgery is required, while the surgical management remains controversial. We aim to further understanding of treatment of FVPTC and to determine whether specific features could be identified for the decision of surgical strategy.

MATERIALS AND METHODS: Data were obtained from the Surveillance, Epidemiology, and End Results (SEER) Program database during 2003 and 2013. 26700 patients were eligible and stratified by tumor size or extension. Survival rates were compared using multivariate Cox proportional hazard regressions.

RESULTS: Of the total death of 1041, 136 patients died from thyroid cancer. Most patients (79.1%) underwent total thyroidectomy while only a little part of patients (8.2%) underwent lobectomy. Patients receiving radioisotopes had significantly better overall survival (OS) (HR = 0.659,

CONCLUSIONS: The results of our study revealed total thyroidectomy could benefit the survival for patients whose tumors > 2 cm with extrathyroidal extension, total thyroidectomy should be recommended for those patients. Lots of factors should be taken into consideration on the decision of surgical treatment.

Keywords: SEER; follicular variant of papillary thyroid carcinoma; surgery

Conflict of interest statement

CONFLICTS OF INTEREST The authors have no conflicts of interest to disclose.

References

  1. Cancer. 2006 Sep 15;107(6):1255-64 - PubMed
  2. Am J Clin Pathol. 2002 Jan;117(1):16-8 - PubMed
  3. Clin Endocrinol (Oxf). 2011 Jul;75(1):112-9 - PubMed
  4. Jpn J Clin Oncol. 2006 Nov;36(11):688-93 - PubMed
  5. Cancer. 2003 Mar 1;97(5):1181-5 - PubMed
  6. Ann Surg Oncol. 2014 Nov;21(12):3844-52 - PubMed
  7. Cancer. 1979 Mar;43(3):810-20 - PubMed
  8. Eur J Cancer. 1979 Aug;15(8):1033-41 - PubMed
  9. Thyroid. 1994 Summer;4(2):233-6 - PubMed
  10. Ann Surg. 2007 Sep;246(3):375-81; discussion 381-4 - PubMed
  11. Surgery. 2004 Sep;136(3):609-16 - PubMed
  12. Thyroid. 2016 Jul;26(7):872-4 - PubMed
  13. Surgery. 2017 Jan;161(1):137-146 - PubMed
  14. Thyroid. 2016 Jan;26(1):1-133 - PubMed
  15. Arch Surg. 2003 Dec;138(12):1362-6 - PubMed
  16. Thyroid. 2013 Oct;23 (10 ):1263-8 - PubMed
  17. Cancer. 1998 Sep 1;83(5):1012-21 - PubMed
  18. World J Surg. 2006 May;30(5):752-8 - PubMed
  19. Clin Oncol (R Coll Radiol). 2017 May;29(5):290-297 - PubMed
  20. Ann Surg Oncol. 2015 Jan;22(1):158-63 - PubMed
  21. J Clin Endocrinol Metab. 1996 Jan;81(1):333-9 - PubMed
  22. J Clin Endocrinol Metab. 2015 Jan;100(1):115-21 - PubMed
  23. Surgery. 1994 Dec;116(6):1036-40; discussion 1040-1 - PubMed
  24. Ann Surg. 1953 Jul;138(1):33-8 - PubMed
  25. Eur J Surg Oncol. 2017 Jan 19;:null - PubMed
  26. Ann Surg Oncol. 1996 Nov;3(6):534-8 - PubMed
  27. Endocr Pathol. 2005 Winter;16(4):323-30 - PubMed
  28. Cancer. 1985 Feb 15;55(4):805-28 - PubMed

Publication Types